Cargando…
Peptide probes derived from pertuzumab by molecular dynamics modeling for HER2 positive tumor imaging
A high level of HER2 expression in breast cancer correlates with a higher tumor growth rate, high metastatic potential, and a poor long-term patient survival rate. Pertuzumab, a human monoclonal antibody, can reduce the effect of HER2 overexpression by preventing HER2 dimerization. In this study, a...
Autores principales: | Yang, Xiaoliang, Wang, Zihua, Xiang, Zhichu, Li, Dan, Hu, Zhiyuan, Cui, Wei, Geng, Lingling, Fang, Qiaojun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5390981/ https://www.ncbi.nlm.nih.gov/pubmed/28406988 http://dx.doi.org/10.1371/journal.pcbi.1005441 |
Ejemplares similares
-
Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors
por: Geng, Lingling, et al.
Publicado: (2015) -
HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
por: Geng, Lingling, et al.
Publicado: (2016) -
Peptosome Coadministration Improves Nanoparticle Delivery to Tumors through NRP1-Mediated Co-Endocytosis
por: Xiang, Zhichu, et al.
Publicado: (2019) -
The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
por: Moya-Horno, I, et al.
Publicado: (2015) -
Clinical efficacy of combination of pertuzumab, trastuzumab, and docetaxel for treatment of patients with HER2-positive breast cancer
por: Liu, Yan-cui, et al.
Publicado: (2019)